For the Inventor, By the Inventor

Enter inventor name

Berlin, Germany

Gerhard Siemeister

USPTO Granted Patents = 77 (Patent Applications = 42)

CIPO Patents = 11 (Patent Applications = 16)

EPO Patents = 55 (Patent Applications = 100)

Average Co-Inventor Count = 7.1

ph-index = 9

Forward Citations = 343(Granted Patents)

Inventors with similar research interests:

Company Filing History:

Bayer Pharma Aktiengesellschaft

Bayer Intellectual Property Gmbh

Schering Aktiengesellschaft

4. 4 out of 192

Bayer Schering Pharma Ag

6. 2 out of 12,157

Bayer Aktiengesellschaft

Bayer Pharma Aktiengesellscaft

where one patent can have more than one assignee

Years Active: 2004-2024

Loading Chart...

Loading Chart...

Loading Chart...

Areas of Expertise:

ATR Kinase Inhibitors

BUB1 Kinase Inhibitors

Macrocyclic Compounds

Fluorinated Derivatives

Sulfoximine Group

Pyrimidine Derivatives

Triazolopyridines

Aminoquinoxalines

Hyper-Proliferative Diseases

Prodrug Derivatives

Imidazopyridazines

Tyrosine Threonine Kinase Inhibitors

77 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11976334 - Inhibitor of ATR kinase for use in a method of treating a hyper-proliferative disease (2024-05-07),

2. 11712440 - Predictive markers for ATR kinase inhibitors (2023-08-01),

3. 11660301 - Combination of ATR kinase inhibitors with PARP inhibitors (2023-05-30),

4. 11529356 - 2-(morpholin-4-yl)-1,7-naphthyridines (2022-12-20),

5. 10772893 - 2-(morpholin-4-yl)-1,7-naphthyridines (2020-09-15),

6. 10729680 - 5-substituted 2-(morpholin-4-yl)-1,7-naphthyridines (2020-08-04),

7. 10717749 - Macrocyclic sulfondiimine compounds (2020-07-21),

8. 10604532 - Substituted benzylindazoles for use as BUB1 kinase inhibitors in the treatment of hyperproliferative diseases (2020-03-31),

9. 10428063 - 4H-pyrrolo[3,2-C]pyridin-4-one derivatives (2019-10-01),

10. 10428044 - 3-amino-1,5,6,7-tetrahydro-4H-indol-4-ones (2019-10-01),

11. 10350206 - Benzyl substituted indazoles as BUB1 inhibitors (2019-07-16),

12. 10308629 - 1H-pyrrol-3-amines (2019-06-04),

13. 10266548 - Substituted benzylindazoles for use as Bub1 kinase inhibitors in the treatment of hyperproliferative diseases (2019-04-23),

14. 10227299 - 3-amino-1,5,6,7-tetrahydro-4H-indol-4-ones (2019-03-12),

15. 10214542 - Modified macrocyclic compounds (2019-02-26),

Certainly! Here is the article about inventor Gerhard Siemeister based on the data provided:

Title: The Innovations of Inventor Gerhard Siemeister

Introduction:

Gerhard Siemeister, a prolific inventor hailing from Berlin, Germany, has made significant contributions to the field of medicine with his groundbreaking patents.

Latest Patents:

Among his extensive portfolio of 76 patents, Gerhard Siemeister's latest innovations include predictive markers for ATR kinase inhibitors and the combination of ATR kinase inhibitors with PARP inhibitors for the treatment of hyper-proliferative diseases.

Career Highlights:

During his career, Gerhard Siemeister has worked with reputable companies such as Bayer Pharma Aktiengesellschaft and Bayer Intellectual Property GmbH, where he has honed his skills and expertise in developing novel therapeutics.

Collaborations:

Siemeister has collaborated closely with esteemed colleagues such as Philip Lienau and Ulrich Lücking, pooling their knowledge and experience to drive innovation in the pharmaceutical industry.

Conclusion:

Inventor Gerhard Siemeister's relentless pursuit of innovation and his groundbreaking patents in the field of medicine have significantly impacted the way hyper-proliferative diseases are treated, solidifying his legacy as a visionary in the world of medical research.

If you have any more specific requests or need further information, feel free to ask!

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…